GSK hiring for new DPI production line at North Carolina facility

According to a spokesperson for GlaxoSmithKline, GSK is aiming to hire a total of 100 employees in 2015 and another 30-40 employees in 2016 for a new DPI assembly line at its Zebulon, NC manufacturing facility. The Zebulon plant, which manufactures and packages 65 million Advair, Breo, Ventolin, Serevent, and Flovent inhalers per year, currently has 850 employees.

GSK broke ground for the 65,000 sq ft addition in March 2015. The new line, which will assemble Ellipta dry powder inhalers, is expected to start up in January 2017.

·

Share

published on

Featured event:

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA

September 24-September 25Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK